Although soluble Gpnmb may be beneficial in the diagnosis and possible therapeutic target of fatty liver disease, brain ischemic injury and ALS, one of the concerns is the possible progression of various malignancies in the clinical application. This evidence concerns the gene GPNMB and fatty liver disease.